Phase II trial of hepatic arterial infusion chemotherapy plus bevacizumab and toripalimab for advanced biliary tract cancers: efficacy, safety, and exploratory analysis [0.03%]
肝动脉灌注化疗序贯贝伐珠单抗和特瑞普利单抗治疗晚期胆道肿瘤患者Ⅱ期临床研究：疗效、安全性及探索性分析
Kanglian Zheng,Shijie Fu,Xu Zhu et al.
Kanglian Zheng et al.
Background: Chemotherapy combined with immune checkpoint inhibitor have prolonged survival of patients with advanced biliary tract cancers (BTCs), and the previous studies showed the synergistic anti-tumor effect of chemo...
Evolution of two-stage hepatectomy: 25 years of modifications and lessons learned [0.03%]
两期肝切除术的演变：25年来的改良和经验教训
Zenichi Morise
Zenichi Morise
Factors associated with textbook outcome after robotic-assisted pancreatoduodenectomy: a single surgeon's retrospective cohort [0.03%]
机器人辅助胰十二指肠切除术后保留幽门的胃窦代胰肠吻合影响因素分析：单中心回顾性队列研究
Ai-Qing Fu,Xi-Tai Huang,Jian-Peng Cai et al.
Ai-Qing Fu et al.
Background: Textbook outcome (TO) represents as an important parameter in assessing the quality of surgical procedures. The factors that contributed to the achievement of the TO in robotic-assisted pancreaticoduodenectomy...
Remote robot-assisted pancreatoduodenectomy for one patient with pancreatic ductal adenocarcinoma [0.03%]
一例胰腺导管腺癌患者的远程机器人辅助胰十二指肠切除术
Chen-Song Huang,Yuan-Yuan Chen,Xi-Tai Huang et al.
Chen-Song Huang et al.
Liver transplantation for hepatocellular carcinoma arising in non-cirrhotic liver: a national-wide retrospective cohort study with propensity score matching analysis in China [0.03%]
中国非肝硬化肝脏原发性肝癌患者的肝移植：全国范围回顾性队列研究及倾向评分匹配分析
Qiang Wei,Nan Xu,Yunguo Lei et al.
Qiang Wei et al.
Background: The majority of liver transplantation (LT) recipients for hepatocellular carcinoma (HCC) present with concomitant liver cirrhosis. However, there is limited research focusing on recipients without cirrhosis. T...
The role of resection margin status on recurrence and selection of patients for adjuvant radiotherapy in distal cholangiocarcinoma [0.03%]
切缘状态对远端胆管癌复发及术后放疗患者选择的作用
Mario De Bellis,Edoardo Poletto,Andrea Ruzzenente
Mario De Bellis
Challenges and innovations in adjuvant therapy for gallbladder cancer: a meta-analytic perspective [0.03%]
胆囊癌辅助治疗的挑战与创新——元分析视角
Daniel Neureiter,Matthias Ocker
Daniel Neureiter
Metabolic syndrome and cholangiocarcinoma: large numbers, small risks, but big implications [0.03%]
代谢综合征与胆管癌：数量庞大，风险较小，但影响深远
Usman Saeed,Sheraz Yaqub
Usman Saeed
Hypovolemic phlebotomy and low central venous pressure: a paradigm shift in liver surgery? [0.03%]
低中心静脉压下的肝叶切除术：一种新的手术范式？
Daniel Eyraud,André Cordeiro
Daniel Eyraud
Should nasogastric enteral feeding become a standard escalation to reverse malnutrition in liver transplant candidates? [0.03%]
鼻胃管肠内喂养应成为逆转肝移植候选人营养不良的标准治疗手段吗？
Alexandra Nassar,Claire Francoz,Christian Hobeika
Alexandra Nassar